top of page

Respiratory Syncytial Virus (RSV) Vaccine

Protection for the Elderly and Immunocompromised Patients

Image by Matt Bennett

What is RSV?

Respiratory Syncytial Virus (RSV) is a highly contagious virus that primarily affects the respiratory tract, causing infections ranging from mild cold-like symptoms to more severe respiratory illnesses such as bronchiolitis and pneumonia. Commonly impacting infants and young children, as well as older adults and individuals with weakened immune systems. 

RSV spreads through respiratory droplets and direct contact with contaminated surfaces. The virus often leads to symptoms like coughing, sneezing, fever, and difficulty breathing. While most cases of RSV resolve on their own, severe infections may require medical attention. Prevention measures include practicing good hygiene, such as frequent handwashing and vaccination. 

Is It Effective and How Much Does It Cost?

Available for adults 60 years of age or older 

OVER 82% EFFECTIVE in preventing lung and lower airway infection from RSV in people aged 60 years and older

OVER 94% EFFECTIVE in preventing lung and lower airway infection from RSV in people aged 60 years and older with asthma, diabetes, chronic obstructive pulmonary disease (COPD), chronic heart failure, advanced liver or kidney disease, or any chronic respiratory or pulmonary disease.

Vaccination consists of a single dose, administered intramuscularly into the deltoid muscle of the upper arm
​
£220/single dose

Avicenna Web Images-099.jpg
Avicenna Web Images-067.jpg

Book an Appointment

We provide a walk-in service, subject to appointment availability, for our professional service. Nevertheless, we highly recommend scheduling an appointment in advance to ensure timely and efficient service

bottom of page